Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and removal of the previous revision (v3.2.0).SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding/operating status notice shown on the page has been removed. This change does not affect the study data, version history, or how users access information on the page.SummaryDifference0.4%

- Check34 days agoChange DetectedOld and New screenshots show the same record history for NCT03521934; only the visual layout appears different, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference9%

- Check70 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.2%

- Check84 days agoChange DetectedThe page now shows Revision: v3.0.2 (up from v3.0.1), indicating a minor update; the "Back to Top" link was removed.SummaryDifference0.6%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.